Thereafter, Dr. Salcedo recommended rotating the claimant’s opioid medications by shifting the claimant from Exalgo to Belbuca and then weaning the claimant off of Fentora.  The provider’s reasoning for the transition of medications was that the current regimen does not provide any functional gains.